Neryzur (Amlodipine Besilate, Nebivolol Hydrochloride)

Amlodipine besilate / nebivolol hydrochloride, the active ingredient in Neryzur, is a calcium channel blocker and beta blocker presented as an oral tablet for oral use. It is indicated for the treatment of hypertension in adult patients.

GNH USA supplies Neryzur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing reliable global distribution.

Neryzur, a combination of a calcium channel blocker and a beta‑blocker, is used to manage elevated blood pressure.

- Essential hypertension: lowers both systolic and diastolic blood pressure and reduces cardiovascular risk. - Isolated systolic hypertension: provides vasodilation while controlling heart rate. - Hypertension with high cardiovascular risk: improves endothelial function and helps lower overall risk.

Adverse reactions may occur with Neryzur and are categorized by frequency.

Common Side Effects: - Headache: mild to moderate intensity. - Peripheral edema: swelling of ankles or lower limbs. - Dizziness or light‑headedness: especially after standing. - Flushing: transient warmth and redness. - Fatigue: general tiredness. - Nasal congestion: mild blockage of nasal passages.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Bradycardia: abnormally slow heart rate. - Heart block: impaired electrical conduction. - Angioedema: swelling of face, lips, or throat. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Allergic reactions: rash, itching, or anaphylaxis.

Before initiating Neryzur, clinicians should consider several safety factors. - Blood pressure monitoring: assess baseline and follow‑up readings. - Heart failure: use with caution and monitor fluid status. - Severe hepatic impairment: dose adjustment may be required. - Pregnancy and lactation: evaluate risk‑benefit and consult a specialist. - Concomitant medications: review for potential interactions. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Neryzur may interact with other medicines; awareness of interaction severity guides management.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): increase plasma concentrations of amlodipine. - Co‑administration with other potent antihypertensives (e.g., ACE inhibitors, ARBs) may cause excessive hypotension. - Non‑dihydropyridine calcium channel blockers (verapamil, diltiazem) with nebivolol can precipitate bradycardia.

Moderate Interactions (Monitor Closely): - Beta‑agonist bronchodilators (e.g., albuterol): may reduce nebivolol efficacy. - Loop or thiazide diuretics: monitor electrolytes and blood pressure. - Alcohol: can enhance hypotensive effect, requiring caution.